Correlation Between Arcus Biosciences and BioNTech

Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arcus Biosciences and BioNTech SE, you can compare the effects of market volatilities on Arcus Biosciences and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and BioNTech.

Diversification Opportunities for Arcus Biosciences and BioNTech

0.3

Correlation Coefficient

Arcus Biosciences  BioNTech

Weak diversification

The 3 months correlation between Arcus and BioNTech is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and BioNTech go up and down completely randomly.

Pair Corralation between Arcus Biosciences and BioNTech

Given the investment horizon of 90 days Arcus Biosciences is expected to generate 1.41 times more return on investment than BioNTech. However, Arcus Biosciences is 1.41 times more volatile than BioNTech SE. It trades about 0.03 of its potential returns per unit of risk. BioNTech SE is currently generating about 0.03 per unit of risk. If you would invest  1,415  in Arcus Biosciences on September 23, 2024 and sell it today you would earn a total of  135.00  from holding Arcus Biosciences or generate 9.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Arcus Biosciences  vs.  BioNTech SE

Arcus Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Arcus Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Arcus Biosciences is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

BioNTech SE

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, BioNTech is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Arcus Biosciences and BioNTech

The main advantage of trading using opposite Arcus Biosciences and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.

The idea behind Arcus Biosciences and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.